Takeda, the manufacturer of Actos, has agreed to pay $nearly $2.4 billion to settle bladder cancer claims brought by users: 

  1. who  took Actos at some time prior to December 1, 2011,
  2. who were diagnosed with bladder cancer on or before April 28, 2015, and
  3. who retained counsel before May 1, 2015. Under the terms of

Takeda Pharmaceutical Co. the manufacture of Actos diabetes medicine has offered to pay more than $2.2 billion to resolve patients’ claims that the drug caused their cancer, according to Bloomberg News. More than 8,000 patients fighting bladder cancer have filed lawsuits in state and federal court. The settlement offer would pay each patient or his heirs